If you’re on Wegovy 2.4 mg and are considering switching to the new Wegovy 7.2 mg dose, you’re probably wondering if it’s actually more effective.
The short answer is yes, the 7.2 mg dose is more effective for weight loss. But the full picture is more nuanced. Let’s break down what the clinical trials showed and what it means for your Wegovy dosage.
What Does ‘Effective’ Mean for Wegovy?
When we talk about how effective Wegovy (semaglutide) is, we’re mainly looking at weight loss. But effectiveness isn’t just about the number on the scales.
For weight loss medications, effectiveness includes average percentage of weight lost, how many people achieve meaningful thresholds (5%, 10%, 15%, or more), and improvements in health markers like blood pressure and cholesterol.
For instance, losing up to 10% of your body weight can result in significant health benefits. And, losing 15% or more sees further improvements.
The Trial Results: 7.2 mg vs 2.4 mg
The STEP UP trial compared the two Wegovy doses head-to-head in 1,407 adults with obesity. All participants followed a reduced-calorie diet and increased their physical activity.
After 72 weeks, people on the highest dose lost 20.7% of their body weight on average, compared to 17.5% on the standard dose.
The gap widens when you look at who hit the highest weight loss targets. About a third of people on 7.2 mg lost a quarter of their body weight or more. On 2.4 mg, that dropped to about one in six people.
If you’re aiming for substantial weight loss – say 20% or more – the higher dose almost doubles (1.8x) your chances of getting there.
Even at the 10% mark, the higher dose performed better. Eighty-six percent of people on 7.2 mg achieved this, compared to 78% on 2.4 mg.
Side Effects
The side effect profile was similar between the two doses. The most common side effects were gastrointestinal: nausea, vomiting, diarrhoea, and constipation. But it’s worth noting that a slightly higher dose means a slightly higher chance of experiencing side effects.
Do You Lose More Weight On Higher Doses Of Wegovy?
Not necessarily. Your response can vary significantly from someone else’s. Some people respond extremely well to 2.4 mg. Others may find they’ve hit a plateau and could benefit from increasing.
With weight loss treatments, higher doses don’t always mean better results. While research shows that the 7.2 mg dose is more effective than 2.4 mg, it doesn’t mean it’s three times as effective despite being three times the dose.
Remember, Wegovy works best for weight management when combined with a reduced-calorie diet and increased physical activity. Increasing your dose won’t compensate for lifestyle factors.
The 7.2 mg dose is designed for people who are doing well on 2.4 mg but need additional support. You need to have gradually increased to the 2.4 mg dose, and have tolerated it well for at least four weeks, before considering an increase.
If you’re happy with your progress on 2.4 mg, there’s no need to switch. Talk to your provider or us about whether the higher dose makes sense for your situation.
Start Now
Key Takeaways
- Wegovy 7.2 mg produces 20.7% average weight loss compared to 17.5% on 2.4 mg over 72 weeks.
- Is Wegovy 7.2 mg effective? Yes, the higher dose almost doubles your chances of achieving 20-25% weight loss.
- Side effects are similar between doses, mostly mild to moderate gastrointestinal issues.
- The 7.2 mg dose is for people tolerating 2.4 mg well but need additional support on their weight loss journey.
References
Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over, NCIB [Accessed: 10 February 2026]
Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence, Novo Nordisk [Accessed: 10 February 2026]
Authorship
Authored by Kate Breen
Content Writer
Kate Breen is a content writer at Simple Online Pharmacy. With 4.5 years of experience across various industries, she specialises in healthcare writing. She holds a BSc in Biology and has worked with healthtech companies, pharmaceutical brands and private clinics. As a chronic illness patient herself, Kate is passionate about making healthcare information accessible by removing jargon and easing patient concerns.
Medically Reviewed by Richard Wood
Pharmacist / Clinical Specialist
GPhC reg:
2078802
Richard is a pharmacist and content reviewer at Simple Online Pharmacy. He officially joined the team in 2024 after several years of working with the company as a contractor. Prior to that, he spent over 11 years as a community pharmacist, building a strong foundation in patient care.
